Table:
begin	end	state
1	33	cytoplasmic
34	54	transmembrane
55	59	non-cytoplasmic
60	79	transmembrane
80	109	cytoplasmic
110	131	transmembrane
132	144	non-cytoplasmic
145	164	transmembrane
165	174	cytoplasmic
175	195	transmembrane
196	218	non-cytoplasmic
219	240	transmembrane
241	260	cytoplasmic
261	283	transmembrane
284	305	non-cytoplasmic
306	325	transmembrane
326	351	cytoplasmic
352	374	transmembrane
375	382	non-cytoplasmic
383	406	transmembrane
407	419	cytoplasmic
420	443	transmembrane
444	448	non-cytoplasmic
449	469	transmembrane
470	489	cytoplasmic

Input:
>WP_094509266.1 NCBI__GCF_002252445.1:WP_094509266.1
MTTEFIKATKAEREVFKEEDSGYHKALKPRQIQMIAIGGAIGTGLFLGAGGRLVQAGPSL
VIVYAVCGFFAFLVLRALGELIMHRPSSGSFVSYAREFYGEKMAFAAGWMYWLNWAMTSI
ADVTAVALYMNFFKHYVPWLEGIDQWMFAMSALILVLSMNLLSVKVFGELEFWFSLVKVL
SLVIFLIVGIYFVVTGTPIDGHQPGFHLIRESGGFFPNGILPALVIIQGVVFAYASIELI
GTTAGETEDPRKIMPGAIKTVVFRLLVFYVGSVLLLTMLLPHTLYSGGESPFVTFFSKIG
VEGADVIMNLVVLTAVLSSLNAGLYSTGRILHSMAVSGSAPASLAKMNKNGVPYVGIAVT
AVVTAIGVALNAFVPAAAFEIALNLASLGIITAWAVIILCQLKLWYLARKGEIARPQFRM
FGAPYTGILTLFFLFGVLVLMAFDYPIGSYTIGSLIIIVPALVIGWYCLRERIYRLAAQR
AAETGHADK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server